文献速递心力衰竭与心肌病肺血管病与心包/心肌炎

镰状细胞病:肺动脉高压与舒张性心力衰竭的交汇点

Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.
PubMed 文献 · Heart · 2019-12-10

本文综述了镰状细胞病(SCD)相关肺动脉高压(PH)与舒张性心力衰竭(HFpEF)的临床表现与机制。SCD患者心肺并发症是主要死因,以舒张性HF和/或PH为主,HF常表现为双心室肥厚和左室舒张功能障碍。PH起源多样,可为毛细血管前、毛细血管后或肺血栓栓塞性,且PH-HFpEF常为毛细血管后起源,出现PH显著降低功能容量并增加死亡率。

要点

  • SCD患者心肺并发症是主要死因,以舒张性HF和/或PH为主。
  • SCD相关HF常表现为双心室肥厚和左室舒张功能障碍。
  • SCD中PH起源多样,PH-HFpEF常为毛细血管后起源。

核心结论

  • SCD患者心肺并发症是主要死因,主要源于舒张性HF和/或PH。
  • SCD相关PH起源多样,且PH存在显著降低功能容量并增加死亡率。
  • PH-HFpEF在SCD中通常为毛细血管后起源。

研究设计与样本

  • 本文为综述,汇总临床与动物研究中关于SCD中PH-HFpEF表现的认识。

主要发现

  • SCD由β珠蛋白基因单点突变引起,导致血红蛋白聚合、红细胞僵硬及低氧低pH条件下溶血。
  • SCD相关HF常表现为双心室肥厚和左室舒张功能障碍。
  • SCD相关PH可为毛细血管前、毛细血管后或肺血栓栓塞性,患者可同时出现毛细血管前和毛细血管后PH,伴左室舒张压升高及跨肺压力梯度和肺血管阻力升高。
  • 无论PH病因如何,其存在均显著降低功能容量并增加死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sickle cell disease (SCD) is caused by a single point mutation in the gene that codes for beta globin synthesis, causing haemoglobin polymerisation, red blood cell stiffening and haemolysis under low oxygen and pH conditions. Downstream effects include widespread vasculopathy due to recurring vaso-occlusive events and haemolytic anaemia, affecting all organ systems. Cardiopulmonary complications are the leading cause of death in patients with SCD, primarily resulting from diastolic heart failure (HF) and/or pulmonary hypertension (PH). HF in SCD often features biventricular cardiac hypertrophy and left ventricular (LV) diastolic dysfunction. Among HF cases in the general population, approximately half occur with preserved ejection fraction (HFpEF). The insidious evolution of HFpEF differs from the relatively acute evolution of HF with reduced ejection fraction. The PH of SCD has diverse origins, which can be pulmonary arterial (precapillary), pulmonary venous (postcapillary) or pulmonary thromboembolic. It is also appreciated that patients with SCD can develop both precapillary and postcapillary PH, with elevations in LV diastolic pressures, as well as elevations in transpulmonary pressure gradient and pulmonary vascular resistance. Regardless of the cause of PH in SCD, its presence significantly reduces functional capacity and increases mortality. PH that occurs in the presence of HFpEF is usually of postcapillary origin. This review aims to assemble what has been learnt from clinical and animal studies about the manifestation of PH-HFpEF in SCD, specifically the contributions of LV diastolic dysfunction and myocardial fibrosis, in an attempt to gain an understanding of its evolution.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Wood KC, Gladwin MT, Straub AC, et al. Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure. Heart. 2019. PMID: 31822569. doi:10.1136/heartjnl-2019-314810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。